Novartis AG
(NYSE : NVS)

( )
NVS PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
ABBVAbbVie, Inc. -0.96%92.131.9%$1192.97m
JNJJohnson & Johnson -0.87%144.440.7%$1057.09m
BMYBristol-Myers Squibb Co. -0.57%60.791.0%$967.46m
PFEPfizer Inc. 0.64%37.500.9%$831.88m
MRKMerck & Co., Inc. -0.22%76.380.7%$796.50m
LLYEli Lilly & Co. -0.69%151.231.1%$417.06m
AZNAstraZeneca Plc -0.11%55.221.2%$261.94m
NVSNovartis AG -0.09%84.910.2%$156.50m
GSKGlaxoSmithKline Plc -0.37%40.880.2%$140.53m
NVONovo Nordisk A/S 0.05%64.850.1%$87.00m
SNYSanofi -0.30%47.300.2%$78.78m
RGENRepligen Corp. -0.57%139.517.1%$73.05m
ARCTArcturus Therapeutics Holdings, Inc. 7.71%58.270.0%$60.48m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 11.80%58.370.0%$42.40m
RETAReata Pharmaceuticals, Inc. 1.04%160.003.4%$38.83m

Company Profile

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.